Matches in Wikidata for { <http://www.wikidata.org/entity/Q95310620> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q95310620 description "article scientifique publié en 2020" @default.
- Q95310620 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95310620 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95310620 description "scientific article published on 19 May 2020" @default.
- Q95310620 description "wetenschappelijk artikel" @default.
- Q95310620 description "наукова стаття, опублікована 19 травня 2020" @default.
- Q95310620 name "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 name "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 type Item @default.
- Q95310620 label "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 label "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 prefLabel "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 prefLabel "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 P1433 Q95310620-3C9098C8-6A41-4D6F-9C8F-1677A6039B10 @default.
- Q95310620 P1476 Q95310620-B5F3A186-46E3-4C2C-AD69-DFB469780313 @default.
- Q95310620 P2093 Q95310620-A00AB306-4426-4CEB-85C7-D84341F29FF9 @default.
- Q95310620 P2093 Q95310620-B94D37DC-37A3-4BCA-8FED-7B41389AD4B9 @default.
- Q95310620 P2093 Q95310620-BE4F720D-4C27-404B-9265-1922612411EF @default.
- Q95310620 P2093 Q95310620-C9447D98-BC97-41A0-A91A-ABAD03D7452D @default.
- Q95310620 P31 Q95310620-FE1FCD10-ED15-4539-9ECE-DD577F57A3D3 @default.
- Q95310620 P356 Q95310620-7BDE54ED-3E51-4379-BF7A-2E70A67A369E @default.
- Q95310620 P577 Q95310620-B0D60A22-7709-4EB7-82E3-4BA0BC9F7841 @default.
- Q95310620 P698 Q95310620-301B5F08-001F-49DC-A929-F359A7400E2F @default.
- Q95310620 P932 Q95310620-B9E5E23D-D7DA-4A53-9262-76FA013D423E @default.
- Q95310620 P356 CAP.2020.0012 @default.
- Q95310620 P698 32423239 @default.
- Q95310620 P1433 Q15756086 @default.
- Q95310620 P1476 "Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder" @default.
- Q95310620 P2093 "Brigitte Robertson" @default.
- Q95310620 P2093 "Elias Sarkis" @default.
- Q95310620 P2093 "Jie Chen" @default.
- Q95310620 P2093 "Lenard A Adler" @default.
- Q95310620 P31 Q13442814 @default.
- Q95310620 P356 "10.1089/CAP.2020.0012" @default.
- Q95310620 P577 "2020-05-19T00:00:00Z" @default.
- Q95310620 P698 "32423239" @default.
- Q95310620 P932 "7475095" @default.